Quarterly report pursuant to Section 13 or 15(d)

Initial Public Offering - Summary of Reconciliation of Common Stock Reflected in the Balance Sheet (Detail)

v3.22.2
Initial Public Offering - Summary of Reconciliation of Common Stock Reflected in the Balance Sheet (Detail) - USD ($)
3 Months Ended 4 Months Ended 6 Months Ended
Jun. 30, 2022
Dec. 31, 2021
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Schedule of Reconciliation of Common Stock Reflected in the Balance Sheet [Line Items]          
Accretion of carrying value to redemption value   $ 21,374,977 $ 63,680 $ 0 $ 63,680
Contingently redeemable common stock $ 234,663,680 234,600,000 234,663,680   234,663,680
Common Stock [Member]          
Schedule of Reconciliation of Common Stock Reflected in the Balance Sheet [Line Items]          
Gross proceeds from IPO   234,600,000      
Proceeds allocated to Public Warrants   (8,740,000)      
Common stock issuance costs   (12,634,977)      
Accretion of carrying value to redemption value 63,680        
Contingently redeemable common stock $ 234,663,680 $ 234,600,000 $ 234,663,680   $ 234,663,680